Skip to main content

Molina Healthcare Inc(MOH-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low150.58
Day High157.31
Open:155.67
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
StockStory
Molina Healthcare (MOH) Stock Is Up, What You Need To Know
MOH
Motley Fool
Molina (MOH) Q4 2025 Earnings Call Transcript
Motley Fool
UnitedHealth Group Surprises Wall Street. Is It Time to Load Up on the Beaten-Down Buffett Stock?
Tipranks
Molina Healthcare (MOH) Receives a Hold from Jefferies
StockStory
Molina Healthcare (MOH) To Report Earnings Tomorrow: Here Is What To Expect
MOH
Tipranks
Mizuho Securities Sticks to Its Buy Rating for Molina Healthcare (MOH)
Tipranks
Bernstein Remains a Buy on Molina Healthcare (MOH)
Tipranks
Barclays Keeps Their Sell Rating on Molina Healthcare (MOH)
Tipranks
Molina Healthcare (MOH) Receives a Buy from Bernstein
MarketBeat
3 Sectors to Buy While They're Down and 1 to Walk Away From
MarketBeat.com
StockStory
2 Profitable Stocks to Consider Right Now and 1 We Question
MOH
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV), Molina Healthcare (MOH) and Ocular Therapeutix (OCUL)
MarketBeat
S&P 500 Rebalancing: 3 Key AI Stocks Earn Their Spot in the Index
MarketBeat.com
Motley Fool
Surging Oil Prices Spark Market Jitters
StockStory
Reflecting On Health Insurance Providers Stocks’ Q4 Earnings: Molina Healthcare (NYSE:MOH)
MOH
Motley Fool
Molina Healthcare Stock Falls 53% as One Fund Adds $8.5 Million. Is It a Buy?
Motley Fool
Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year
Motley Fool
Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue
StockStory
1 Unpopular Stock That Should Get More Attention and 2 We Avoid
HUBG
Motley Fool
Solas Capital Loads Up On Kyndryl With 407,000 Shares Bought
Tipranks
Molina Healthcare Reaffirms 2026 Earnings Guidance to Investors
StockStory
1 Cash-Burning Stock with Promising Prospects and 2 We Avoid
LCID
StockStory
Molina Healthcare (MOH): Buy, Sell, or Hold Post Q4 Earnings?
MOH
StockStory
2 Small-Cap Stocks to Target This Week and 1 We Brush Off
MIR
StockStory
2 of Wall Street’s Favorite Stocks Worth Your Attention and 1 We Turn Down
DOCS
StockStory
2 Cash-Heavy Stocks with Competitive Advantages and 1 Facing Challenges
COIN
Tipranks
Molina Healthcare (MOH) Gets a Hold from Truist Financial
StockStory
Moderna, Vertex Pharmaceuticals, Integra LifeSciences, Baxter, and Molina Healthcare Shares Are Soaring, What You Need To Know
MRNA
Tipranks
Molina Healthcare’s Margins at Risk as Medicaid Rates Lag Rising Medical Costs
StockStory
1 Healthcare Stock Worth Your Attention and 2 Facing Challenges
REGN
StockStory
Molina Healthcare’s Q4 Earnings Call: Our Top 5 Analyst Questions
MOH
Tipranks
Analysts Offer Insights on Healthcare Companies: Medpace Holdings (MEDP) and Molina Healthcare (MOH)

Profile

Molina Healthcare Inc. is a multi-state managed care organization participating exclusively in government-sponsored healthcare programs such as the Medicaid program and the State Children's Health Insurance Program (SCHIP), catering to low-income persons. The company provides managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The company currently operates in two segments: Health Plans and Other. The company manages most of its operations through the Health Plans segment.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.